Financials in USD. Standardized financial statements.
A compact view of how Chembio Diagnostics, Inc. turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $48.34M | $36.93M | $30.45M | $34.46M | $33.41M | $24.02M | $17.87M | $24.26M | $27.65M | $29.55M |
| Revenue Growth? | +30.9% | +21.3% | -11.6% | +3.2% | +39.1% | +34.4% | -26.3% | -12.3% | -6.4% | 0.0% |
| Cost of Revenue? | $38.58M | $34.50M | $23.87M | $22.39M | $21.43M | $12.92M | $9.42M | $13.77M | $16.83M | $17.25M |
| Gross Profit? | $9.76M | $2.43M | $6.58M | $12.07M | $11.98M | $11.09M | $8.45M | $10.49M | $10.81M | $12.30M |
| Gross Margin? | +20.2% | +6.6% | +21.6% | +35.0% | +35.9% | +46.2% | +47.3% | +43.2% | +39.1% | +41.6% |
| Operating Expenses? | $30.16M | $26.44M | $28.53M | $24.68M | $19.63M | $17.58M | $16.02M | $14.04M | $12.36M | $11.30M |
| Operating Income? | -$20.40M | -$24.01M | -$21.95M | -$12.61M | -$7.65M | -$6.48M | -$7.57M | -$3.55M | -$1.55M | $1.00M |
| EBITDA? | -$14.61M | -$21.07M | -$19.25M | -$861.01M | -$7.31M | -$5.18M | -$6.41M | -$2.18M | -$810,824 | $1.63M |
| Income Before Tax | -$23.26M | -$33.97M | -$25.98M | -$14.18M | -$7.93M | -$6.46M | -$7.55M | -$3.56M | -$1.55M | $1.02M |
| Income Tax Expense | $34,405 | -$62,050 | -$456,794 | -$500,292 | -$67,521 | -$88,305 | $5.80M | -$1.16M | -$412,918 | $486,952 |
| Net Income? | -$23.29M | -$33.90M | -$25.52M | -$13.68M | -$7.87M | -$6.37M | -$13.35M | -$2.40M | -$1.14M | $530,818 |
| EPS? | $-0.96 | $-1.40 | $-1.34 | $-0.81 | $-0.54 | $-0.52 | $-1.26 | $-0.25 | $-0.12 | $0.06 |
| Diluted EPS? | $-0.96 | $-1.40 | $-1.34 | $-0.81 | $-0.54 | $-0.52 | $-1.26 | $-0.25 | $-0.12 | $0.06 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality